Where could SIBN trade next? Consensus target price: $23.
Get informed when a big investor buys or sells
+ Follow$18.3
3 analysts in the last 4 months
High: $25 | Low: $21
No recommendations in the last 4 months.
SI-BONE (SIBN) currently reports a target price of $23. Use the charts on this page to explore SI-BONE's target price history and peer comparisons.
Analysts' average 12-month price target for SI-BONE is $23, about 27.5% upside from the current share price of $18.3. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.
Start with the current target price of $23, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for SI-BONE, and consider following SIBN for alerts when major investors trade the stock.
SI-BONE is classified in the Healthcare sector. On target price, it currently shows $23. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SIBN with unrelated industries.